Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Top 10 Value Stocks to Buy Under $10

In this article, we will discuss the Top 10 Value Stocks to Buy Under $10.

On June 16, Julian Emanuel, Chief Equity & Quantitative Strategist at Evercore, joined CNBC’s ‘Squawk on the Street’ to discuss what’s driving the markets and his bull case for the S&P 500. Emanuel asserted that the recent market rally is driven not only by a potential peace deal with Iran but also significantly by the impact of the SpaceX IPO. He highlighted that the public remains highly engaged in equity market investing, particularly in tech stocks, and noted that the public has consistently led professionals in these trends over the past several years. Despite professional skepticism surrounding the SpaceX IPO, the public was fully enthused, a sentiment now reflected in the company’s stock price. Furthermore, Emanuel noted that the recent decline in oil prices, bringing it down to a seven-handle, serves as an unexpected and significant positive for the market.

Regarding his outlook for the S&P 500, Emanuel maintains a target of 7,750, but explained that current conditions open the door for his bull case target of 9,000. He explained that tech-driven structural bull markets typically conclude due to recession or a Fed that is hiking interest rates; however, he argued that these threats are rapidly diminishing due to the decline in oil prices and the lack of upward movement in long-end yields. He identified the final element that typically ends a bull market as a period of intense fear of missing out, driven by capital markets, which he believes is still ahead. Additionally, he pointed out that earnings power has exceeded expectations, meaning market multiples remain unstretched despite the significant gains.

Our Methodology

We used screeners to identify stocks that are trading below $10 per share and below a forward P/E of 15, and limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. These stocks are also popular among analysts and elite hedge funds.

Note: All data was sourced on June 16. 

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Insider Monkey’s quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 599.2% since May 2014, beating its benchmark by 372 percentage points (see more details here).

Top 10 Value Stocks to Buy Under $10

10. Aegon Ltd. (NYSE:AEG)

Number of Hedge Fund Holders: 14

Aegon Ltd. (NYSE:AEG) is one of the top value stocks to buy under $10. On May 28, Aegon announced an agreement with its largest shareholder, Vereniging Aegon, and a new governance framework to support the company’s planned relocation to the US. This move is designed to align Aegon’s corporate structure with US market standards as it pursues its goal of becoming a leading US-focused life insurance and retirement group.

Key governance changes include moving the legal seat to Delaware, implementing annual director elections, and simplifying the capital structure by converting all Common Shares B into a single class of stock with equal voting rights. Additionally, the company will introduce annual Say-on-Pay advisory votes and authorize a new class of preferred stock to match customary US practices.

As part of the restructuring, Vereniging Aegon will be renamed Vereniging Aegon Americas while retaining its 18.4% ownership stake. The organization will donate EUR 500 million to a new Netherlands-based charitable entity, Stichting Aegon Fonds Nederland, ensuring the continuation of its social impact initiatives. These changes remain subject to shareholder approval at an Extraordinary General Meeting scheduled for Q4 2026.

Aegon Ltd. (NYSE:AEG) is an international financial services holding company. The company provides products and services across insurance, long-term savings, banking, and asset management.

9. Nomura Holdings Inc. (NYSE:NMR)

Number of Hedge Fund Holders: 15

Nomura Holdings Inc. (NYSE:NMR) is one of the top value stocks to buy under $10. On May 29, Reuters reported that Nomura’s digital asset subsidiary, Laser Digital, has received conditional approval from the Office of the Comptroller of the Currency for a national trust bank charter in the US. Upon final sign-off, the firm will be authorized to hold and administer both conventional and digital assets under federal supervision. The company will focus on institutional services, explicitly excluding deposit-taking and lending.

The new subsidiary, Laser Digital National Trust Bank, aims to facilitate cross-border payments and collateral management across crypto and traditional markets. This expansion into the U.S. market is supported by a clearer regulatory environment, driven by legislative developments like the GENIUS Act, which have boosted institutional confidence in tokenized assets and stablecoins.

This move reflects a broader trend of legacy financial institutions increasing their investment in digital asset infrastructure. With at least 15 similar bank charter applications submitted to the OCC since 2025, Laser Digital joins other major firms in integrating digital assets into the mainstream financial system.

Nomura Holdings Inc. (NYSE:NMR) is a Japanese multinational financial company. It offers wealth management, investment banking, and brokerage services, among others. Nomura was founded in 1925 and operates across the Americas, Europe, and Asia.

8. Melco Resorts & Entertainment Limited (NASDAQ:MLCO)

Number of Hedge Fund Holders: 16

Melco Resorts & Entertainment Limited (NASDAQ:MLCO) is one of the top value stocks to buy under $10. On June 9, Melco Resorts & Entertainment extended the maturity date of its existing revolving credit facilities from April 2027 to June 2031. Additionally, the company has established an incremental facility of approximately $821.6million, bringing the total commitment under the credit arrangement to approximately $2.77 billion.

The extension and expansion were formalized through a third amended and restated facility agreement, which maintains the pricing and financial covenants of the original 2020 agreement. Melco’s subsidiary, MCO Nominee One Limited, will pay customary fees to the participating lenders in connection with these updates.

This financial adjustment provides Melco Resorts & Entertainment Limited (NASDAQ:MLCO) with enhanced capital flexibility to support its operations as a developer and operator of integrated resorts across Asia and Europe. The company continues to manage its debt structure strategically amidst evolving market conditions in its key gaming jurisdictions.

Melco Resorts & Entertainment Limited (NASDAQ:MLCO) is a global developer and operator of integrated resort casinos, hotels, and entertainment complexes, primarily in Asia, offering gaming, hospitality, and leisure experiences.

7. Grifols (NASDAQ:GRFS)

Number of Hedge Fund Holders: 16

Grifols (NASDAQ:GRFS) is one of the top value stocks to buy under $10. On June 15, Grifols launched FESILTY in the US for treating acute bleeding in pediatric and adult patients with congenital fibrinogen deficiency/CFD, excluding dysfibrinogenemia. This highly purified human-derived fibrinogen concentrate provides a precise, targeted treatment for a rare genetic condition where insufficient clotting proteins compromise wound healing.

Compared to traditional options like cryoprecipitate or fresh frozen plasma, FESILTY allows for faster, more predictable dosing without needing large-volume infusions or cross-matching. It comes in a complete kit that can be stored at room temperature and reconstituted in approximately three minutes, making it effective for time-sensitive bleeding events.

FDA approval for this therapy was supported by Phase I/III clinical study data, which confirmed its safety, pharmacokinetic properties, and hemostatic efficacy. While effective, the product carries risks, including potential hypersensitivity and thrombotic events, and is contraindicated in patients with severe hypersensitivity to its components.

Grifols (NASDAQ:GRFS) is a global healthcare company specializing in plasma-derived medicines. Founded in Barcelona in 1909, it provides biopharmaceutical products and medical services in over 110 countries.

6. ​Haleon (NYSE:HLN)

Number of Hedge Fund Holders: 19

​Haleon (NYSE:HLN) is one of the top value stocks to buy under $10. On June 4, Haleon issued a voluntary nationwide recall for four specific lots of Gas-X Extra Strength Softgels (125mg) in 120-count and 72-count packaging. The recall was initiated due to potential contamination from a diluted propylene glycol-based coolant that leaked from a machine during the packaging process.

While ​Haleon (NYSE:HLN) has not received any reports of adverse health events to date, ingestion of the contaminated softgels could potentially lead to symptoms such as nausea, vomiting, abdominal pain, and diarrhea. The recall is being conducted in coordination with the US FDA as a precautionary measure.

Consumers are advised to check their product packaging against the affected lot numbers, which include TL8K, YH9X, and YH9Y for the 120-count packages, and X78N for the 72-count packages. No other versions or lots of Gas-X products are included in this recall, and the company has confirmed that the affected products were distributed between April 13 and May 14.

​Haleon (NYSE:HLN), together with its subsidiaries, researches, develops, manufactures, and sells various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

While we acknowledge the potential of HLN to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than HLN and that has 100x upside potential, check out our report about the cheapest AI stock.

Click to continue reading and see the Top 5 Value Stocks to Buy Under $10.

Disclosure: None. None. Follow Insider Monkey on Google News.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.